THE PUBLIC campaign against patent policies in the US is important for the rest of the world, because it is the Washington model that has set global standards for the stifling monopoly rights enjoyed by innovator drug companies. So when a group of leading public organisations recently asked the US Secretary of Health and Human Services Xavier Becerra to use his executive power to override patent rights on six important therapies, it signals the growing pressure on the US administration to curtail monopoly patent rights on the drugs it helps to develop; either through research collaboration with the National Institutes of Health (NIH) or public funding. Such a measure would widen access to life-saving medicines and reduce their prices.
The COVID-19 pandemic has prompted health activists to pursue such a strategy, spurred by the dispute between NIH and Moderna Inc over patent rights to the biotech company's mRNA COVID-19 vaccine. Moderna's vaccine was developed in collaboration with scientists of NIH who had earlier done the vital groundwork on mRNA technology, the reason why the vaccine could be developed in a short time. Yet, Moderna excluded key NIH scientists when it filed patent claims on the vaccine (see 'Bizarre patent tussles over a COVID-19 jab', Down To Earth 1-15 March, 2022) allowing it to rake in huge profits. Who really owns the intellectual property rights (IPRS) on the vaccine is a vital question in these pandemic times. If NIH insists on its innovator rights, that means the public organisation can license the technology to companies of its choice, in addition to receiving a share of the US $18 billion profits that Moderna is forecast to earn this year.
Bu hikaye Down To Earth dergisinin May 01, 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Down To Earth dergisinin May 01, 2022 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
In leading role again
MOVIES AND WEB SERIES ARE ONCE AGAIN BEING SET IN RUSTIC BACKGROUNDS, INDICATING A RECONNECT BETWEEN CINEMA AND THE COUNTRYSIDE
One Nation One Subscription comes at a huge cost
As top US universities scrap big deals with top scientific publishers, India’s ONOS scheme seems flawed and outdated
Return of Rambhog
Bid to revive and sell the aromatic indigenous paddy variety has led to substantial profits for farmers in Uttar Pradesh's Terai region
Scarred by mining
Natural springs of Kashmir drying up due to illegal riverbed mining
Human-to-human spread a mutation away
CANADA IN mid-November confirmed its first human case of avian influenza, with a teenager in the British Columbia being hospitalised after contracting the H5N1 virus that causes the disease. The patient developed a severe form of the disease, also called bird flu, and had respiratory issues. There was no known cause of transmission.
True rehabilitation
Residents of Madhya Pradesh's Kakdi village take relocation as an opportunity to undertake afforestation, develop sustainable practices
INESCAPABLE THREAT
Chemical pollution is the most underrated and underreported risk of the 21st century that threatens all species and regions
THAT NIGHT, 40 YEARS AGO
Bhopal gas disaster is a tragedy that people continue to face
A JOKE, INDEED
A CONFERENCE OF IRRESPONSIBLE PARTIES THAT CREATED AN OPTICAL ILLUSION TO THE REALITY OF A NEW CLIMATE
THINGS FALL APART
THE WORLD HAS MADE PROGRESS IN MITIGATING EMISSIONS AND ADAPTING TO CLIMATE IMPACTS. BUT THE PROGRESS REMAINS GROSSLY INADEQUATE